Form 4: Broadwood Partners Increases Stake in STAAR Surgical Co.

Broadwood Partners, L.P., along with related entities and individuals, reports acquiring additional shares of STAAR Surgical Co. common stock, increasing their beneficial ownership.

Summary

• On March 31, 2025, Broadwood Partners acquired 22,189 shares of STAAR Surgical Co. common stock at a weighted average price of $17.4573.
• On April 2, 2025, Broadwood Partners acquired 31,780 shares of STAAR Surgical Co. common stock at a weighted average price of $17.43.
• Following these transactions, Broadwood Partners directly owns 12,487,044 shares of STAAR Surgical Co. common stock.
• Neal C. Bradsher also directly owns 25,900 shares.
• Broadwood Capital, Inc., as General Partner of Broadwood Partners, and Neal C. Bradsher, as President of Broadwood Capital, may be deemed to indirectly beneficially own the shares held by Broadwood Partners.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating increased ownership, which can be seen as a positive signal, but it doesn't contain any explicit forward-looking statements or strong endorsements.

Positives

• Broadwood Partners increased its investment in STAAR Surgical Co., signaling confidence in the company's prospects.

Industry Context

This filing reflects ongoing investment activity in the healthcare sector, specifically in companies like STAAR Surgical Co. that focus on ophthalmic surgical products.

Stakeholder Impact

• The increased stake by Broadwood Partners could be viewed positively by shareholders, potentially increasing investor confidence.

Key Dates

Keywords

STAAR Surgical Co, Broadwood Partners, Beneficial Ownership, Stock Acquisition, Form 4, STAA, Shares